Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Jan 26, 2023

SELL
$11.49 - $13.65 $1,298 - $1,542
-113 Reduced 5.96%
1,784 $0
Q3 2022

Nov 22, 2022

SELL
$12.41 - $32.42 $9,853 - $25,741
-794 Reduced 29.51%
1,897 $23,000
Q2 2022

Aug 19, 2022

BUY
$19.63 - $26.62 $51,548 - $69,904
2,626 Added 4040.0%
2,691 $52.8 Million
Q1 2022

May 11, 2022

SELL
$24.65 - $29.0 $40,919 - $48,140
-1,660 Reduced 96.23%
65 $2,000
Q4 2021

Jan 21, 2022

SELL
$27.74 - $34.09 $25,770 - $31,669
-929 Reduced 35.0%
1,725 $49,000
Q3 2021

Nov 12, 2021

BUY
$29.2 - $36.72 $15,622 - $19,645
535 Added 25.25%
2,654 $86,000
Q2 2021

Jul 30, 2021

BUY
$28.76 - $35.98 $60,942 - $76,241
2,119 New
2,119 $75,000

Others Institutions Holding ELAN

About Elanco Animal Health Inc


  • Ticker ELAN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 474,113,984
  • Market Cap $6.63B
  • Description
  • Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet...
More about ELAN
Track This Portfolio

Track Eagle Bay Advisors LLC Portfolio

Follow Eagle Bay Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eagle Bay Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Eagle Bay Advisors LLC with notifications on news.